Triana-Martínez, Francisco
Picallos-Rabina, Pilar http://orcid.org/0000-0001-5673-5952
Da Silva-Álvarez, Sabela
Pietrocola, Federico
Llanos, Susana http://orcid.org/0000-0002-8555-9326
Rodilla, Verónica http://orcid.org/0000-0003-0512-4179
Soprano, Enrica http://orcid.org/0000-0001-6786-9729
Pedrosa, Pablo
Ferreirós, Alba http://orcid.org/0000-0002-7003-8683
Barradas, Marta http://orcid.org/0000-0001-7122-7251
Hernández-González, Fernanda
Lalinde, Marta
Prats, Neus
Bernadó, Cristina
González, Patricia
Gómez, María
Ikonomopoulou, Maria P. http://orcid.org/0000-0001-7739-080X
Fernández-Marcos, Pablo J. http://orcid.org/0000-0003-3515-4125
García-Caballero, Tomás
del Pino, Pablo http://orcid.org/0000-0003-1318-6839
Arribas, Joaquín
Vidal, Anxo
González-Barcia, Miguel
Serrano, Manuel http://orcid.org/0000-0001-7177-9312
Loza, María I.
Domínguez, Eduardo http://orcid.org/0000-0003-3359-5867
Collado, Manuel http://orcid.org/0000-0002-0330-0880
Article History
Received: 22 June 2019
Accepted: 7 October 2019
First Online: 21 October 2019
Change Date: 16 September 2020
Change Type: Correction
Change Details: An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Competing interests
: M.S. is founder and advisor of Senolytic Therapeutics, Inc. The remaining authors declare no competing interests.